[
    "{\"step_by_step_thinking\": \"Document 0, 1, 2, 3, 5, 6, 7, 8, 10, 13, 14, 15, 17, 21 all mention that deucravacitinib has been effective in treating psoriasis in clinical trials. These documents provide evidence that deucravacitinib has shown significant improvement in patients with moderate-to-severe psoriasis, with over 50% of patients reaching PASI75, a measure of psoriasis severity, and also improving quality of life outcomes. Therefore, based on these documents, it can be concluded that deucravacitinib is effective for psoriasis.\", \"answer_choice\": \"A\"}"
]